Therapeutic strategies for high-risk neuroblastoma

Katarzyna Radke

Therapeutic strategies for high-risk neuroblastoma

Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

Originalspråk	engelska
Kvalifikation	Doktor
Tilldelande institution	Institutionen för laboratoriemedicin
Handledare	Bexell, Daniel, handledare Aaltonen, Kristina, Biträdande handledare
Tilldelningsdatum	2023 juni 8
Utgivningsort	Lund
Förlag	Lund University, Faculty of Medicine
ISBN (tryckt)	978-91-8021-419-3
Status	Published - 2023

Bibliografisk information

Defence details
Date: 2023-06-08
Time: 09:00
Place: Stora Hörsalen, Medicon Village, Scheelevägen 2 i Lund. Zoom: https://lu-se.zoom.us/j/5313973517?pwd=TlE4MlBIckdOWlpJQWtaLzNzL0hnZz09
External reviewer(s)
Name: Chesler, Louis
Title: Professor
Affiliation: Institute of Cancer Research, London, UK

Ämnesklassifikation (UKÄ)

Cell- och molekylärbiologi

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

2 Artikel i vetenskaplig tidskrift

Anti-tumor effects of rigosertib in high-risk neuroblastoma
Radke, K., Hansson, K., Sjölund, J., Wolska, M., Karlsson, J., Esfandyari, J., Pietras, K., Aaltonen, K., Gisselsson, D. & Bexell, D., 2021 aug., I: Translational Oncology. 14, 8, 101149.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
Hansson, K., Radke, K., Aaltonen, K., Saarela, J., Mañas, A., Sjölund, J., Smith, E. M., Pietras, K., Påhlman, S., Wennerberg, K., Gisselsson, D. & Bexell, D., 2020, I: Science Translational Medicine. 12, 562, eaba4434.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Citera det här

@phdthesis{428b57644373464bb9b438bee137780d,

title = "Therapeutic strategies for high-risk neuroblastoma",

keywords = "cancer, neuroblastoma, drug testing, preclinical cancer models, drug combination",

author = "Katarzyna Radke",

note = "Defence details Date: 2023-06-08 Time: 09:00 Place: Stora H{\"o}rsalen, Medicon Village, Scheelev{\"a}gen 2 i Lund. Zoom: https://lu-se.zoom.us/j/5313973517?pwd=TlE4MlBIckdOWlpJQWtaLzNzL0hnZz09 External reviewer(s) Name: Chesler, Louis Title: Professor Affiliation: Institute of Cancer Research, London, UK",

year = "2023",

language = "English",

isbn = "978-91-8021-419-3",

series = "Lund University, Faculty of Medicine Doctoral Dissertation Series",

publisher = "Lund University, Faculty of Medicine",

number = "2023:79",

type = "Doctoral Thesis (compilation)",

school = "Department of Laboratory Medicine",

}

TY - THES

T1 - Therapeutic strategies for high-risk neuroblastoma

AU - Radke, Katarzyna

N1 - Defence details Date: 2023-06-08 Time: 09:00 Place: Stora Hörsalen, Medicon Village, Scheelevägen 2 i Lund. Zoom: https://lu-se.zoom.us/j/5313973517?pwd=TlE4MlBIckdOWlpJQWtaLzNzL0hnZz09 External reviewer(s) Name: Chesler, Louis Title: Professor Affiliation: Institute of Cancer Research, London, UK

PY - 2023

Y1 - 2023

KW - cancer

KW - neuroblastoma

KW - drug testing

KW - preclinical cancer models

KW - drug combination

M3 - Doctoral Thesis (compilation)

SN - 978-91-8021-419-3

T3 - Lund University, Faculty of Medicine Doctoral Dissertation Series

PB - Lund University, Faculty of Medicine

CY - Lund

ER -

Therapeutic strategies for high-risk neuroblastoma

Bibliografisk information

Ämnesklassifikation (UKÄ)

FN:s Globala mål

Forskningsoutput

Anti-tumor effects of rigosertib in high-risk neuroblastoma

Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

Citera det här